SOFLEX UV-ABSORBING SILICONE POSTERIOR CHAMBER INTRAOCULAR LENS
Bausch + Lomb, Inc. · Decision date Jan 17, 1992
What did the FDA approve?
FDA records P910056 as an original PMA application. The recorded decision is approval, dated Jan 17, 1992.
An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Ophthalmic
- Decision date
- Jan 17, 1992
Regulatory record facts
- Identifier
- P910056
- Regulatory pathway
- Premarket approval application
- Applicant
- Bausch + Lomb, Inc.
- Product code
- HQL
- Decision code
- APPR
- Decision date
- Jan 17, 1992
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Applicant
- Bausch + Lomb, Inc.
- Product code
- HQL
- FDA device class
- 3
FDA decision timeline
P910056 received
Application receipt date recorded by FDA.
P910056 · FDA decision
APPR
P910056/S063 · Related supplement
enVista hydrophobic acrylic intraocular lens
P910056/S065 · Related supplement
enVista Aspire Hydrophobic Acrylic Intraocular Lens (IOL)
P910056/S064 · Related supplement
enVista Hydrophobic Acrylic Intraocular Lens
P910056/S066 · Related supplement
enVista Hydrophobic Acrylic Intraocular Lens
P910056/S067 · Related supplement
enVista Hydrophobic Acrylic Intraocular Lens
Timeline entries are records held by MedtechLedger for P910056. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P910056
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
enVista hydrophobic acrylic intraocular lensP910056/S063 | Bausch + Lomb, Inc. | PMA supplement | Sep 3, 2026 | FDA |
| Bausch + Lomb, Inc. | PMA supplement | Sep 29, 2026 | FDA | |
enVista Hydrophobic Acrylic Intraocular LensP910056/S064 | Bausch + Lomb, Inc. | PMA supplement | Sep 30, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S066 | Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038/S004 | Beaver-Visitec International, Inc. | PMA supplement | Oct 27, 2026 | FDA |
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
FINEVISION HP Trifocal IOLsP240038/S003 | Beaver-Visitec International, Inc. | PMA supplement | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bausch + Lomb, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 50 Technology Dr., Irvine, CA, 92618
Sources and methodology
- Original FDA record: P910056
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





